United Kingdom

People: CytomX Therapeutics Inc (CTMX.OQ)

CTMX.OQ on NASDAQ Stock Exchange Global Select Market

6:32pm BST
Change (% chg)

$0.33 (+3.06%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Young, Matthew 

Mr. Matthew P. Young is Lead Independent Director of the company, he was Independent Director of the company. Mr. Young has served as a member of our board of directors since September 2015. Mr. Young has been Executive Vice President and Chief Financial Officer of Jazz Pharmaceuticals plc since February 2015 and previously served as its Senior Vice President and Chief Financial Officer since March 2014 and as its Senior Vice President, Corporate Development since April 2013. Prior to joining Jazz Pharmaceuticals, Mr. Young worked in investment banking for approximately 20 years. From February 2009 to April 2013, Mr. Young served as a managing director in global healthcare of Barclays Capital Inc., an investment banking firm, where his role included acting as the co-head of life sciences at Barclays Capital. From 2007 to 2008, Mr. Young served as a managing director of Citigroup Global Markets Inc., an investment banking firm, and from 2003 to 2007, as a managing director of Lehman Brothers Inc., an investment banking firm. From 1992 to 2003, Mr. Young served in various capacities at other investment banking firms. In 2015, he joined the board of directors of PRA Health Sciences, Inc., a public contract research company. Mr. Young received a B.S. in Economics and a M.B.A. from the Wharton School of the University of Pennsylvania.

Basic Compensation

Total Annual Compensation, USD 53,750
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 114,848
Fiscal Year Total, USD 168,598

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --